What is the current Herpes Testing Kits market size?

The current Herpes Testing Kits market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Herpes Testing Kits market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Herpes Testing Kits market?

Key drivers include rising awareness, technological advancements, and growing healthcare expenditure.

What challenges does the Herpes Testing Kits market face?

The market faces challenges such as social stigma, limited awareness, and stringent regulatory requirements.

Which regions are the leaders in the Herpes Testing Kits market?

North America and Europe are the regional leaders, accounting for over 60% of the market share.

Who are the top companies in the Herpes Testing Kits market?

Top companies include Abbott Laboratories, Roche Diagnostics, and bioMerieux, offering a range of testing solutions.

What future opportunities exist in the Herpes Testing Kits market?

Future opportunities include the development of point-of-care testing and home-based testing kits, expanding market reach.

How will technology impact the Herpes Testing Kits market?

Technological advancements will drive the market, with molecular diagnostics and PCR-based tests gaining traction.

What is the regulatory landscape for the Herpes Testing Kits market?

The market is subject to stringent regulatory requirements, including FDA and CE markings, ensuring product safety and efficacy.

What is the future outlook for the Herpes Testing Kits market?

The future outlook is positive, with the market expected to reach USD 2.5 billion by 2033, driven by growing demand.

Herpes Testing Kits Growth Analysis & Future Outlook 2033

Herpes Testing Kits by Application (Diagnostic Centers, Hospitals, Home Use), by Types (Antibody/Antigen Based Kit, Viral Culture Test Kits, Nucleic Acid Amplification-based Kits), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Herpes Testing Kits Market Overview

The Herpes Testing Kits market refers to the industry that provides diagnostic kits for the detection of herpes viruses. The Herpes Testing Kits market size is estimated to be around $1.4 billion in 2025, with a growth outlook that is expected to drive the market to reach $2.5 billion by 2033. As the market forecast suggests, the industry is poised for significant expansion, driven by increasing awareness about herpes infections and the need for accurate diagnosis. The industry expansion is expected to be fueled by technological advancements, government initiatives, and the rising demand for point-of-care testing kits.

Loading chart…

The Herpes Testing Kits market is expected to grow at a CAGR of 7.5% during the forecast period, driven by macro drivers such as increasing healthcare expenditure, rising awareness about herpes infections, and advancements in diagnostic technologies. Key forces shaping the industry include technology shifts towards point-of-care testing, regulations that favor the use of diagnostic kits, and consumer behavior that demands convenient and accurate testing solutions. The largest region for the Herpes Testing Kits market is North America, while the fastest-growing region is Asia Pacific, driven by increasing healthcare infrastructure and rising demand for diagnostic kits.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; ADI/American Diagnostica; Agilent Technologies; Chrono-Log; Corgenix; Decode Genetics; Diadexus; Diagnocure; Diagnostica Stago/Trinity Biotech; Diamedix; International Technidyne/Nexus DX; Kreatech/Leica; Polymedco; Qiagen; Roche; SDIX; Sequenom; Siemens
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Herpes Testing Kits market is poised for significant growth, driven by increasing awareness and prevalence of herpes infections. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advances in diagnostic technologies have led to the development of more accurate and efficient Herpes Testing Kits, driving growth in the Herpes Testing Kits market size. This, in turn, has increased adoption rates among healthcare providers and patients.

Government initiatives and public-private partnerships aimed at promoting Herpes Testing Kits and improving access to diagnostic services have contributed to the growth forecast of the market, particularly in developing regions.

Restraints2 items

High costs associated with some Herpes Testing Kits, particularly those that require specialized equipment or reagents, can limit adoption in resource-constrained settings, affecting the overall Herpes Testing Kits market.

Stringent regulatory requirements for the approval and clearance of Herpes Testing Kits can delay market entry for new products, potentially hindering innovation and the growth forecast of the market.

Opportunities2 items

The increasing demand for point-of-care (POC) Herpes Testing Kits presents opportunities for manufacturers to develop user-friendly, rapid diagnostic solutions that can be used in various settings, contributing to the expansion of the Herpes Testing Kits market size.

Emerging markets, with their large and growing populations, offer significant untapped potential for Herpes Testing Kits manufacturers, driven by improving healthcare infrastructure and increasing awareness about herpes infections, which can influence the growth forecast.

Challenges2 items

The Herpes Testing Kits market faces challenges related to ensuring the quality and reliability of test results, particularly with the proliferation of rapid diagnostic tests that may vary in sensitivity and specificity, impacting the overall Herpes Testing Kits market size.

Maintaining supply chain integrity and managing inventory levels to meet fluctuating demands for Herpes Testing Kits can be complex, especially during global health crises, affecting the growth forecast of the market.

Market Segmentation

Loading chart…

The Herpes Testing Kits segmentation by Application includes various categories such as Diagnosis, Blood Screening, and Research. Each of these categories contributes significantly to the overall market size. For instance, the Diagnosis segment holds a substantial share of the market, driven by the increasing prevalence of herpes and the need for timely diagnosis. This segment is further divided into subcategories, including Type 1 and Type 2 herpes diagnosis, each with its own set of testing kits and procedures.

The Herpes Testing Kits market can also be segmented by Types, which includes PCR, Serology, and Rapid Tests. These types of testing kits are used for detecting the presence of herpes virus in the body. The PCR segment is expected to dominate the market due to its high accuracy and sensitivity. The Serology segment, on the other hand, is expected to grow at a steady rate, driven by its cost-effectiveness and ease of use. Understanding the market taxonomy of these segments is crucial for industry players to develop effective strategies and stay competitive in the market.

Herpes Testing Kits Segmentation Breakdown8 items

Application

Diagnostic Centers

Hospitals

Home Use

Types

Antibody/Antigen Based Kit

Viral Culture Test Kits

Nucleic Acid Amplification-based Kits

Regional Insights

Loading chart…

The Herpes Testing Kits market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and rising investments in research and development.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include favorable policies, a strong ecosystem, and significant investments in healthcare. Asia Pacific is driven by a large and growing population, increasing adoption of diagnostic technologies, and strategic investments. Latin America and Middle East & Africa are driven by improving infrastructure, rising adoption, and government policies supporting healthcare development.

The regional forecast indicates that Asia Pacific will experience the highest Herpes Testing Kits market growth, with a compound annual growth rate (CAGR) of 8%. North America and Europe will maintain their market share, while Latin America and Middle East & Africa will experience moderate growth. Understanding these regional trends is crucial for stakeholders to navigate the global Herpes Testing Kits market effectively.

Competitive Landscape

The Herpes Testing Kits market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Herpes Testing Kits competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service model, and channel strength.

Companies in the market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to maintain a competitive edge. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies must develop unique value propositions and strategic focuses. Some notable strategies include:

Abbott: regional expansion

Agilent Technologies: innovation pipeline

Qiagen: premium pricing

Roche: OEM tie-ups

Siemens: local manufacturing

Diadexus: vertical integration

Key Herpes Testing Kits Companies18 items

Abbott

ADI/American Diagnostica

Agilent Technologies

Chrono-Log

Corgenix

Decode Genetics

Diadexus

Diagnocure

Diagnostica Stago/Trinity Biotech

Diamedix

International Technidyne/Nexus DX

Kreatech/Leica

Polymedco

Qiagen

Roche

SDIX

Sequenom

Siemens

Market Ecosystem

The Herpes Testing Kits ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. The ecosystem boundaries stretch across the value chain, with value created and captured at various stages, including research and development, manufacturing, distribution, and deployment. Understanding the Herpes Testing Kits ecosystem requires a thorough value chain analysis, examining the interactions and interdependencies among participants.

Raw material/component suppliers — provide diagnostic reagents

OEMs / manufacturers — produce testing kits

Technology providers — develop diagnostic technologies

Distributors / channel partners — supply kits to healthcare providers

Service providers / after-sales — offer maintenance and support services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish testing and safety standards

The flow of value in the Herpes Testing Kits ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and supply chain disruptions, can also affect the ecosystem. Additionally, switching costs, partnerships, and interoperability requirements can influence the decisions of end users and other participants. The ecosystem's dynamics can vary by region, with different regulatory frameworks, healthcare systems, and market conditions shaping the interactions among participants.

Recent Industry Insights

The Herpes Testing Kits industry has witnessed significant developments over the last 12-18 months, shaping the Herpes Testing Kits industry trends. Recent partnerships between leading manufacturers and research institutions have accelerated the development of more accurate and rapid testing solutions. Notably, the industry has seen strategic mergers and acquisitions, such as the acquisition of a prominent diagnostic company by a major healthcare firm, expanding the reach and capabilities of Herpes Testing Kits.

Furthermore, there have been notable product launches, including the introduction of point-of-care testing devices that offer enhanced convenience and accessibility. Regulatory changes, such as updated guidelines for testing and diagnosis, have also influenced the market. A shift in consumer trends towards at-home testing has driven demand for user-friendly and reliable Herpes Testing Kits. Additionally, funding rounds and expansions by key players have supported research and development efforts, underscoring the growth potential of the Herpes Testing Kits industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Herpes Testing Kits market outlook. The market attractiveness is moderate, driven by increasing awareness and rising demand for diagnostic testing. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with opportunities for growth in emerging markets and innovation in testing technologies.

The innovation landscape is evolving, with advancements in point-of-care testing and molecular diagnostics. Demand-supply balance is expected to be stable, with key risk factors including regulatory changes and supply chain disruptions. Overall, the Herpes Testing Kits market is expected to experience steady growth, driven by increasing demand for accurate and reliable diagnostic testing.

11 items

1. Executive Summary

2. Herpes Testing Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Herpes Testing Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Herpes Testing Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diagnostic Centers

6.1.2. Hospitals

6.1.3. Home Use

6.2. Global Herpes Testing Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Antibody/Antigen Based Kit

6.2.2. Viral Culture Test Kits

6.2.3. Nucleic Acid Amplification-based Kits

6.3. Global Herpes Testing Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Herpes Testing Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Herpes Testing Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Herpes Testing Kits Market Competition by Key Manufacturers

8.1. Global Herpes Testing Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Herpes Testing Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ADI/American Diagnostica

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Agilent Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Chrono-Log

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Corgenix

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Decode Genetics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Diadexus

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Diagnocure

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Diagnostica Stago/Trinity Biotech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Diamedix

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. International Technidyne/Nexus DX

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Kreatech/Leica

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Polymedco

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Qiagen

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Roche

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. SDIX

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Sequenom

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Siemens

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Herpes Testing Kits Market

Figure 4: Global Herpes Testing Kits Market: Drivers

Figure 5: Global Herpes Testing Kits Market: Challenges

Figure 6: Global Herpes Testing Kits Market: Trends

Figure 7: Global Herpes Testing Kits Market: Opportunity

Figure 8: Global Herpes Testing Kits Market: Restraint

Figure 9: Global Herpes Testing Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Herpes Testing Kits Market Value (USD Million) By Region

Figure 15: Global Herpes Testing Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Herpes Testing Kits Market Value (USD Million) By Region

Figure 23: Global Herpes Testing Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Herpes Testing Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Herpes Testing Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Herpes Testing Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Herpes Testing Kits Market Value (USD Million) By Region

Table 10: Global Herpes Testing Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Herpes Testing Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Herpes Testing Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Herpes Testing Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: ADI/American Diagnostica Basic Information And Sales Area

Table 33: ADI/American Diagnostica. Products Portfolio

Table 34: Agilent Technologies Basic Information And Sales Area

Table 35: Agilent Technologies. Products Portfolio

Table 36: Chrono-Log Basic Information And Sales Area

Table 37: Chrono-Log. Products Portfolio

Table 38: Corgenix Basic Information And Sales Area

Table 39: Corgenix. Products Portfolio

Table 40: Decode Genetics Basic Information And Sales Area

Table 41: Decode Genetics. Products Portfolio

Table 42: Diadexus Basic Information And Sales Area

Table 43: Diadexus. Products Portfolio

Table 44: Diagnocure Basic Information And Sales Area

Table 45: Diagnocure. Products Portfolio

Table 46: Diagnostica Stago/Trinity Biotech Basic Information And Sales Area

Table 47: Diagnostica Stago/Trinity Biotech. Products Portfolio

Table 48: Diamedix Basic Information And Sales Area

Table 49: Diamedix. Products Portfolio

Table 50: International Technidyne/Nexus DX Basic Information And Sales Area

Table 51: International Technidyne/Nexus DX. Products Portfolio

Table 52: Kreatech/Leica Basic Information And Sales Area

Table 53: Kreatech/Leica. Products Portfolio

Table 54: Polymedco Basic Information And Sales Area

Table 55: Polymedco. Products Portfolio

Table 56: Qiagen Basic Information And Sales Area

Table 57: Qiagen. Products Portfolio

Table 58: Roche Basic Information And Sales Area

Table 59: Roche. Products Portfolio

Table 60: SDIX Basic Information And Sales Area

Table 61: SDIX. Products Portfolio

Table 62: Sequenom Basic Information And Sales Area

Table 63: Sequenom. Products Portfolio

Table 64: Siemens Basic Information And Sales Area

Table 65: Siemens. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Herpes Testing Kits Market Value (USD Million) By Region

Table 71: Global Herpes Testing Kits Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Herpes Testing Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; ADI/American Diagnostica; Agilent Technologies; Chrono-Log; Corgenix; Decode Genetics; Diadexus; Diagnocure; Diagnostica Stago/Trinity Biotech; Diamedix; International Technidyne/Nexus DX; Kreatech/Leica; Polymedco; Qiagen; Roche; SDIX; Sequenom; Siemens
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Herpes Testing Kits Segmentation Breakdown8 items

Application

Diagnostic Centers

Hospitals

Home Use

Types

Antibody/Antigen Based Kit

Viral Culture Test Kits

Nucleic Acid Amplification-based Kits

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

Agilent Technologies: innovation pipeline

Qiagen: premium pricing

Roche: OEM tie-ups

Siemens: local manufacturing

Diadexus: vertical integration

Key Herpes Testing Kits Companies18 items

Abbott

ADI/American Diagnostica

Agilent Technologies

Chrono-Log

Corgenix

Decode Genetics

Diadexus

Diagnocure

Diagnostica Stago/Trinity Biotech

Diamedix

International Technidyne/Nexus DX

Kreatech/Leica

Polymedco

Qiagen

Roche

SDIX

Sequenom

Siemens

Market Ecosystem

Raw material/component suppliers — provide diagnostic reagents

OEMs / manufacturers — produce testing kits

Technology providers — develop diagnostic technologies

Distributors / channel partners — supply kits to healthcare providers

Service providers / after-sales — offer maintenance and support services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish testing and safety standards

Recent Industry Insights

Analyst Overview

Table of Contents